~~<i id='E53BC2F80D'><strike id='E53BC2F80D'><tt id='E53BC2F80D'><pre id='E53BC2F80D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

Wikipedia

author：fashion 2025-09-27 19:29:27 - browse：68791

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease.

If things go well, Roche could pay Alnylam up to $2.8 billion in total.

Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug firms have struggled to one-up existing treatments for high blood pressure and high cholesterol that are now available as cheap generics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Midwives could help bridge maternal health disparities in the U.S.

hotspot

focus

knowledge

hotspot

explore

hotspot

4:11ChiefofstaffMarkMeadowslistensasPresidentDonaldTrumpspeaksintheOvalOfficeoftheWhiteHouseonSept.1

WSS

Idaho college killings prosecutors challenge defense's grand jury claims

Eli Lilly CEO gives to Mike Pence presidential super PAC

House panel takes first step toward fixing drug shortages

After Optum profits sink, UnitedHealth makes changes

What happened to the House vote on health price transparency?

Megan Rapinoe shares emotional post following US Women's World Cup exit

leisure time

Wikipedia

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Malaria cases in Florida and Texas: Here’s what you need to know

What happened to the House vote on health price transparency?

United colonoscopy coverage change 'may cost lives,' doctors say

Senators push IRS to launch nonprofit hospital probe

Guidelines to prevent youth baseball injuries need more muscle

Akili changes sales model for its ADHD video game treatment

Medical records are filled with copy

Maui wildfire now ranks as the fifth

focus

Assistant physicians can help address the primary care shortage

House panel takes first step toward fixing drug shortages

Schizophrenia gene found to be linked to cells' energy dysfunction

Senate bill would ban some hospital facility fees

After Optum profits sink, UnitedHealth makes changes

Bird flu researchers hone in on Finland’s mink farms

knowledge

hotspot

explore

hotspot